Rizatriptan Benzoate Tablet
Product Images NDC 82619-111

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 82619-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Creekwood Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (10mg 1000 Tablets)

Rizatriptan Benzoate Tablets, USP 10 mg, oral dosage form label for a bottle containing 1000 tablets. The label includes storage instructions, dosage information, manufacturer V-Ensure Pharma Technologies Pvt. Ltd., and distributor Creekwood Pharmaceuticals LLC. It also features a barcode and a note for pharmacists to dispense with a patient information leaflet.*

FDA Label Image

Image Description (10mg 2x6 Tablets)

Rizatriptan Benzoate Tablets, USP 10 mg oral tablet carton from Creekwood Pharmaceuticals LLC. The package contains 12 tablets (2 x 6 Unit-of-Use Tablets). Printed storage and dosage instructions, barcode, NDC 82619-112-04, and manufacturer details from V-Ensure Pharma Technologies Pvt. Ltd, India, are visible on the label.*

FDA Label Image

Image Description (5mg 1000 Tablets)

Label for Rizatriptan Benzoate Tablets, USP 5 mg, oral tablets in a package of 1000, distributed by Creekwood Pharmaceuticals LLC. The label includes storage instructions (20° to 25°C), manufacturing and distribution information, a barcode, and notes on dispensing and pharmacist instructions. It is marked Rx Only.*

FDA Label Image

Image Description (5mg 2x6 Tablets)

The packaging label for Rizatriptan Benzoate Tablets, USP, 5 mg strength, shows a blister pack containing 12 unit-of-use tablets (2 x 6). The label features the Creekwood Pharmaceuticals LLC logo and branding, includes NDC number 82619-111-04, and notes the tablets are for oral use, prescription only. It includes storage instructions, dosage reference, and manufacturer information for V-Ensure Pharma Technologies Pvt. Ltd. in India, distributed by Creekwood Pharmaceuticals LLC in New Jersey, USA.*

FDA Label Image

Image Description (Chemical Structure)

Chemical structure diagram of rizatriptan benzoate, showing the molecular arrangement of the active ingredient in the human prescription drug tablets marketed by Creekwood Pharmaceuticals LLC.*

FDA Label Image

Image Description (Figure 01)

A line graph showing the estimated probability of response over hours post-dose for placebo, RIZATRIPTAN BENZOATE 5 mg, and RIZATRIPTAN BENZOATE 10 mg. The x-axis represents hours post-dose from 0 to 2, and the y-axis shows the estimated probability of response from 0% to 100%. Both RIZATRIPTAN BENZOATE doses show a higher response probability compared to placebo over time.*

FDA Label Image

Image Description (Figure 02)

A line graph showing the estimated probability of remediation or rescue over 24 hours post-dose for placebo, 5 mg, and 10 mg doses of rizatriptan benzoate. The graph compares the response rates over time, with placebo achieving the highest probability followed by 5 mg and 10 mg doses.*

FDA Label Image

Image Description (Figure 05)

A line graph comparing the percentage (with 95% confidence intervals) over time in hours post second dose between Rizatriptan Benzoate and placebo. The x-axis shows hours post second dose from 0.5 to 2.0, and the y-axis shows percentage from 0 to 100%. Rizatriptan Benzoate is represented by a solid line and placebo by a dashed line, with Rizatriptan Benzoate showing higher percentages at each time point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.